Check out our most popular compounded medications! Get Started
The Lorazepam 1 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg/Metoclopramide 20 mg Suppository is a compounded medication. This solid dosage form is inserted into a body cavity, typically the rectum or vagina, where it dissolves or melts. The medication is then released for local or systemic absorption. It is used to treat conditions such as insomnia, anxiety, schizophrenia, nausea, and vomiting.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The Bayview Pharmacy team of compounding pharmacists has meticulously developed a suppository formulation of Lorazepam 1 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg/Metoclopramide 20 mg. This unique formulation is designed to address a range of disease states, including anxiety, insomnia, nausea, and vomiting.
The combination of Lorazepam and Diphenhydramine HCl in this formulation works synergistically to alleviate anxiety and promote restful sleep. Concurrently, Haloperidol and Metoclopramide are included for their efficacy in reducing nausea and vomiting.
For patients, this suppository formulation offers a user-friendly and efficient method of medication administration. It is designed to dissolve or melt once inserted into a body cavity, typically the rectum or vagina, releasing the medication for local or systemic absorption. This allows for rapid relief from symptoms. It is crucial, however, to adhere strictly to the usage instructions provided by your healthcare provider to ensure optimal results and safety.
For healthcare providers, this formulation presents a potent and versatile treatment option for managing anxiety, insomnia, nausea, and vomiting in patients. It is essential to consider the potential side effects of the individual components when prescribing this formulation. We encourage healthcare providers to contact us with any queries or concerns about this formulation. Our team is committed to providing comprehensive information and support to ensure the best possible patient outcomes.
The Lorazepam 1 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg/Metoclopramide 20 mg Suppository is a compounded formulation designed for the treatment of various conditions such as nausea, vomiting, anxiety, and agitation. Each component of this formulation plays a specific role in managing these conditions. Lorazepam, a benzodiazepine, is utilized for its calming effects on the brain and nerves, thus helping to reduce anxiety and agitation. Haloperidol, an antipsychotic medication, is used to manage agitation. Lastly, Metoclopramide, a prokinetic agent, aids in the treatment of nausea and vomiting.
Patients should be aware that this formulation may cause side effects such as drowsiness, dizziness, and confusion. It is advised not to drive or operate machinery until the effects of the medication are fully understood. Additionally, this formulation may cause an increase in blood pressure, heart rate, and respiration. Regular monitoring for these side effects is recommended.
It is important to note that this formulation may interact with other medications, including but not limited to antacids, anticonvulsants, antihistamines, and other benzodiazepines. Therefore, patients should inform their healthcare provider of all medications they are currently taking before starting this treatment.
Healthcare providers prescribing this formulation should also be aware of the potential for increased blood pressure, heart rate, and respiration in patients. Regular monitoring for these side effects is advised. Additionally, potential interactions with other medications, including antacids, anticonvulsants, antihistamines, and other benzodiazepines, should be considered.
If you have any questions or concerns about this formulation or its potential interactions, please do not hesitate to contact your healthcare provider for further information and guidance.
This compounded formulation combines Lorazepam 1 mg, Diphenhydramine HCl 12.5 mg, Haloperidol 2 mg, and Metoclopramide 20 mg in a suppository form. Each of these active ingredients serves a specific purpose in treating a variety of conditions such as anxiety, insomnia, nausea, and vomiting.
Lorazepam, a benzodiazepine, is known for its ability to alleviate anxiety and induce sleep. Haloperidol, an antipsychotic medication, is used to manage anxiety and agitation. Lastly, Metoclopramide, a prokinetic agent, is utilized to mitigate nausea and vomiting.
The suppository is designed to be inserted into the rectum, where it dissolves to release the medication. The active ingredients are then absorbed into the bloodstream, with the effects typically felt within 30 minutes to 1 hour.
It is crucial to use this formulation as directed by a healthcare provider. It is not recommended for children under the age of 18. Prior to using this formulation, it is advisable to discuss potential side effects with your healthcare provider. This ensures that you are fully informed about the medication and can make an informed decision about your treatment.
If you have any questions or concerns about this formulation or its mechanism of action, please do not hesitate to contact us at Bayview Pharmacy. We are committed to helping you find the most suitable treatment option for your condition.
This compounded formulation of Lorazepam 1 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg/Metoclopramide 20 mg Suppository is a versatile medication that can be used to treat a wide range of conditions. Additionally, it can be used to alleviate symptoms associated with muscle spasms, irritable bowel syndrome, and motion sickness.
One of the key advantages of this formulation is its suppository form, which is especially beneficial for patients who have difficulty swallowing pills or capsules. The suppository is inserted into a body cavity, typically the rectum or vagina, where it dissolves or melts to release the medication. This allows for quick absorption and can provide relief within minutes.
This formulation can also be used to manage symptoms of opioid withdrawal, such as nausea, vomiting, and muscle spasms. However, it is crucial to note that this medication should only be used under the supervision of a healthcare professional. Patients should discuss any potential risks and benefits with their doctor before using this formulation.
It's important to be aware that this formulation may cause drowsiness. As such, it should not be used while operating a motor vehicle or machinery. Always ensure to use this medication responsibly and in accordance with the advice of your healthcare provider.
If you have any questions about this formulation or any other compounding medications, please don't hesitate to reach out. We are here to help you find the best treatment option for your individual needs.
This is a compounded medication that combines Lorazepam, Diphenhydramine, Haloperidol, and Metoclopramide in a solid dosage form. It is designed to be inserted into a body cavity, typically the rectum or vagina, where it dissolves or melts to release the medication for local or systemic absorption.
This medication is typically used to manage symptoms such as nausea, vomiting, agitation, and anxiety, particularly in palliative care settings. The combination of these four drugs can provide comprehensive symptom management.
The suppository should be inserted into the rectum or vagina as directed by your healthcare provider. It will dissolve or melt to release the medication.
Side effects can include drowsiness, dizziness, dry mouth, constipation, blurred vision, or unsteadiness. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Consult your healthcare provider before using this medication if you are pregnant, planning to become pregnant, or are breastfeeding. The effects on the fetus or infant are not fully known.
If you miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Use your next dose at the regular time. Do not double the dose to catch up.
Alcohol can increase the nervous system side effects of these medications such as dizziness, drowsiness, and difficulty concentrating. It is best to avoid or limit the use of alcohol while being treated with these medications.
If you experience signs of an allergic reaction such as rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing, seek medical attention immediately.
This medication may cause drowsiness or dizziness. Do not drive, use machinery, or do anything that needs alertness until you can do it safely.
Store at room temperature away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository
